Summary
Updated Aug 31, 2026
Steve Pakola is Chief Medical Officer of REGENXBIO Inc. (RGNX). 6 SEC Form 4 filings on record, most recently on 4 August 2026. Most recent open-market trade: sold $29K of RGNX on 6 July 2026. Lifetime open-market sales: $940K.
Recent Transactions
9Every recent SEC Form 4 transaction Steve Pakola has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Steve Pakola go back to 2026: 6 primary Form 4 filings, an average of 6.0 per year. 5 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Steve Pakola files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gregory Austin Ciongoli - $949K of RGNX open-market activity in the last 12 months
- Curran Simpson - $417K of RGNX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Steve Pakola?
Steve Pakola is a corporate insider, tracked as Chief Medical Officer of REGENXBIO Inc. (RGNX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Steve Pakola submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Steve Pakola been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($940K) across all tracked filings.
Where can I see all of Steve Pakola's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Steve Pakola and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial